EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyse

Systematic Review and Meta-analysis of Baseline Neutrophil-Lymphocyte Ratio Predicting Prognosis in Cancer Patients Treated with Immune Checkpoint Inhibitors

Cancer Immuno Perspectives · 2025

DOI: 10.70996/cip.00010 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Cancer Immuno Perspectives, 2025.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To methodically assess the prognostic predictive value of baseline neutrophil-to-lymphocyte ratio (NLR) in cancer patients receiving immune checkpoint inhibitor (ICI) therapy.

Methods

We conducted a systematic search in PubMed, Embase, Cochrane Library, and Web of Science. The search covered studies from each database's founding to December 31, 2024. We included cohort studies or post hoc analyses from randomized controlled trials that assessed the association between baseline NLR (neutrophil-to-lymphocyte ratio) and the prognosis of ICI (immunotherapy) treatment. The Newcastle-Ottawa Scale, a tool for quality assessment of non-randomized studies, was used. Random-effect models combine effect sizes across studies. Subgroup analysis (examining results within subgroups), meta-regression (statistical exploration of heterogeneity), and sensitivity analysis (testing the robustness of the results) were performed.

Results

Sixty-eight studies, including 18,947 patients, were analyzed. Patients with high NLR (neutrophil-to-lymphocyte ratio) had significantly poorer overall survival (OS, time until death from any cause) compared to those with low NLR (combined HR=1.96, 95% CI: 1.74-2.21, P

Zitieren

APA

(2025). Systematic Review and Meta-analysis of Baseline Neutrophil-Lymphocyte Ratio Predicting Prognosis in Cancer Patients Treated with Immune Checkpoint Inhibitors. Cancer Immuno Perspectives. https://doi.org/10.70996/cip.00010

Vancouver

Systematic Review and Meta-analysis of Baseline Neutrophil-Lymphocyte Ratio Predicting Prognosis in Cancer Patients Treated with Immune Checkpoint Inhibitors. Cancer Immuno Perspectives. 2025. doi:10.70996/cip.00010

BibTeX
@article{euvimed2025,
  title = {Systematic Review and Meta-analysis of Baseline Neutrophil-Lymphocyte Ratio Predicting Prognosis in Cancer Patients Treated with Immune Checkpoint Inhibitors},
  journal = {Cancer Immuno Perspectives},
  year = {2025},
  doi = {10.70996/cip.00010}
}
Kostenlos starten →